US Patent Issued to Takeda Pharmaceutical on July 22 for "Human plasma-derived IGG preparation enriched in anti-parvo B19 natural IGGS" (Austrian Inventors)

ALEXANDRIA, Va., July 23 -- United States Patent no. 12,365,723, issued on July 22, was assigned to Takeda Pharmaceutical Co. Ltd. (Osaka, Japan).

"Human plasma-derived IGG preparation enriched in anti-parvo B19 natural IGGS" was invented by Lucia Gnauer (Ebersbrunn, Austria), Harald Arno Butterweck (Vienna), Theresa Bauer (Vienna), Alfred Weber (Vienna), Wolfgang Teschner (Vienna) and Hans-Peter Schwarz (Vienna).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods are provided for the manufacture of plasma-derived immunoglobulin G compositions highly enriched for anti-parvo B19 immunoglobulin G. The methods provided do not affect the manufacturing processes or capabilities for producing plasma-derived IgG ...